Changeflow GovPing Healthcare & Life Sciences Expandable Implant Delivery Device for BPH Trea...
Routine Notice Added Final

Expandable Implant Delivery Device for BPH Treatment

Email

Summary

USPTO published patent application US20260108343A1 on April 23, 2026 for an expandable implant delivery device and method for treating benign prostatic hyperplasia (BPH) within the prostatic urethra. The device comprises an inner tube and an outer sleeve moveable between stored and deployed positions, with the expandable implant retained within an annulus defined between the tube and sleeve when stored. Inventors: Riona Ni Ghriallais and Conor Harkin. Application No. 19285888 filed July 30, 2025.

“Aspects of the present invention relate to a method for locating an expandable implant for treating BPH within the prostatic urethra of a patient.”

USPTO , verbatim from source
Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USPTO Patent Applications - Prosthetics (A61F) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 211 changes logged to date.

What changed

USPTO published patent application US20260108343A1 on April 23, 2026 for an expandable implant delivery device designed to treat BPH in the prostatic urethra. The application discloses a device comprising an inner tube and outer sleeve moveable relative to each other between stored and deployed positions, with the expandable implant retained within the annulus when the sleeve is in the stored position. Patent applications do not create compliance obligations for third parties; they represent intellectual property filings that may be relevant to manufacturers, researchers, and investors in the medical device space.

Archived snapshot

Apr 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

EXPANDABLE IMPLANT DELIVERY DEVICE

Application US20260108343A1 Kind: A1 Apr 23, 2026

Inventors

Riona Ni Ghriallais, Conor Harkin

Abstract

Aspects of the present invention relate to a method for locating an expandable implant for treating BPH within the prostatic urethra of a patient. The delivery device comprises an inner tube and an outer sleeve moveable relative to the inner tube between a stored position and a deployed position. The outer sleeve surrounds the inner tube to define an annulus therebetween and the expandable implant is retained within the annulus when the outer sleeve is in the stored position.

CPC Classifications

A61F 2/04 A61F 2/966 A61B 1/307 A61F 2002/047

Filing Date

2025-07-30

Application No.

19285888

View original document →

Get daily alerts for USPTO Patent Applications - Prosthetics (A61F)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Patent application Medical device filing
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Medical Devices Healthcare

Get alerts for this source

We'll email you when USPTO Patent Applications - Prosthetics (A61F) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!